No Data
No Data
Weikang Pharmaceutical (300878.SZ) and related personnel received a warning letter from Zhejiang Securities Regulatory Bureau
Weikang Pharmaceutical (300878.SZ) announced that the company and relevant responsible personnel received it on May 27, 2024...
Focusing on the pharmaceutical manufacturing industry, Weikang Pharmaceutical (300878.SZ) plans to sell 2 retail chain business subsidiaries
Weikang Pharmaceutical (300878.SZ) announced that Zhejiang Weikang Pharmaceutical Commercial Co., Ltd., a wholly-owned subsidiary of the company (“Weikang...
Weikang Pharmaceutical (300878.SZ) plans to pay 2.5 yuan for 10 shares to be deducted from interest on May 29
Weikang Pharmaceutical (300878.SZ) announced that the company's 2023 equity distribution plan: to all shareholders for every 10...
Weikang Pharmaceutical (300878.SZ): Elected Liu Yang as Chairman of the 4th Board of Directors of the Company
Gelonghui, May 21, 丨 Weikang Pharmaceutical (300878.SZ) announced that on May 20, 2024, the first meeting of the fourth board of directors deliberated and agreed to elect Liu Yang as the chairman of the fourth board of directors for a term of three years, from the date of review and approval of the current board of directors until the end of the term of the fourth board of directors.
Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected
Those holding Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) shares would be relieved that the share price has rebounded 29% in the last thirty days, but it needs to keep going to repair
Weikang Pharmaceutical (300878.SZ): A total cost of 49.998 million yuan to buy back 1.89% of the shares
Gelonghui, Feb. 27丨Weikang Pharmaceutical (300878.SZ) announced that as of the disclosure date of this announcement, the company had repurchased 2,739,026 shares through a dedicated repurchase account, accounting for 1.89% of the company's total share capital. The highest transaction price was 20.08 yuan/share, the minimum transaction price was 16.66 yuan/share, and the total transaction amount was 49,998,352 yuan. The company's current repurchase plan has been implemented. The actual time period for share repurchase is from February 19, 2024 to February 26, 2024.
No Data